Skip to main content
. 2014 Dec 21;17(7):953–964. doi: 10.1093/neuonc/nou330

Fig. 2.

Fig. 2.

Effect of dasatinib on DIPG cell line in vitro. (A) DIPG cell lines (NEM), T98G, and SF188 were treated with the indicated doses of dasatinib or vehicle for 3 days and growth was measured using the confluence algorithm. Results are the mean percent inhibition compared with control cells ± SEM of 3 experiments carried out in triplicate. (B) Representative classification of dasatinib sensitivity by IC50 determination for each cell line. (C) Contrast phase fluorescent images of NEM168 12 h posttreatment. Nuclear staining indicates loss of membrane integrity. Scale bar = 300 µM. (D) Cells were plated in complete medium with or without the indicated dose of dasatinib or vehicle for 72 h, stained with annexin V and propidium iodide, and analyzed by flow cytometer, as described in Materials and Methods. Apoptosis detected in the control cells was set to 1 and is represented by the dashed line. Results are the mean ± SD of duplicate representatives of 3 experiments carried out. (E) Distribution of cells in sub-G1, G1, S, G2, and super-G2 phases was determined after propidium iodide staining and by using the Dean-Jet-Fox algorithm in FlowJo software.